TXMD

TherapeuticsMD, Inc. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website erapeuticsmd.com
Employees(FY) 1
ISIN US88338N2062

Performance

-11.2%

-14.62%

-35.47%

-40.32%

-50.67%

YTD

-51.95%

Profile

TherapeuticsMD, Inc. operates as a pharmaceutical company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY,BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Advanced Technical Analysis

Technical Analysis of TXMD 2024-12-20

The stock indicators present a mixed sentiment, with a bearish Moving Average Score of 10 and a neutral Technical Score of 36, while the Oscillators Score at 63 indicates a bullish outlook. Overall, the combination suggests a cautious approach, as the bullish oscillator may not be enough to offset the bearish and neutral signals from the other i...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of TXMD

Stock Rank

Recent News & Updates

2024-11-12 03:32
TherapeuticsMD: Q3 Earnings Snapshot(Yahoo Finance)
2024-11-12 03:05
TherapeuticsMD Announces Third Quarter 2024 Financial Results(Businesswire)
2024-08-12 05:26
TherapeuticsMD: Q2 Earnings Snapshot(Yahoo Finance)
2024-08-12 04:05
TherapeuticsMD Announces Second Quarter 2024 Financial Results(Businesswire)
2024-06-27 23:52
TXMD Stock Earnings: TherapeuticsMD Reported Results for Q4 2023(Investorplace)
2024-05-10 08:53
TXMD Stock Earnings: TherapeuticsMD Reported Results for Q1 2024(Investorplace)
2024-05-10 04:43
TherapeuticsMD: Q1 Earnings Snapshot(Yahoo Finance)
2024-05-10 04:05
TherapeuticsMD Announces First Quarter 2024 Financial Results(Businesswire)
2024-03-29 04:00
TherapeuticsMD Announces Full Year 2023 Financial Results(Businesswire)
2024-03-11 23:40
25 Countries With Highest Abortion Rates(Insidermonkey)
2024-01-30 10:20
12 Best Prenatal Vitamins For Pregnant Women(Yahoo Finance)
2023-11-14 16:08
TherapeuticsMD: Q3 Earnings Snapshot(Yahoo Finance)
2023-11-14 03:05
TherapeuticsMD Announces Third Quarter 2023 Financial Results(Businesswire)
2023-08-13 19:52
TherapeuticsMD: Q2 Earnings Snapshot(Yahoo Finance)
2023-08-13 18:50
TherapeuticsMD Announces Second Quarter 2023 Financial Results(Yahoo Finance)
2023-05-15 05:56
TherapeuticsMD: Q1 Earnings Snapshot(Yahoo Finance)
2023-05-15 04:05
TherapeuticsMD Announces First Quarter 2023 Financial Results(Yahoo Finance)
2023-04-14 00:00
All You Need to Know About TherapeuticsMD (TXMD) Rating Upgrade to Buy(Yahoo Finance)
2023-04-07 04:01
TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition(Yahoo Finance)
2023-01-02 17:50
TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma(Yahoo Finance)
2022-12-07 21:42
Boca pharma company will cut 212 employees after failed buyout(Yahoo Finance)
2022-12-04 05:00
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma(Yahoo Finance)
2022-11-14 06:55
TherapeuticsMD (TXMD) Reports Q3 Loss, Lags Revenue Estimates(Yahoo Finance)
2022-11-14 03:05
TherapeuticsMD Announces Third Quarter 2022 Financial Results(Yahoo Finance)
2022-10-30 18:50
TherapeuticsMD Announces Additional $7 Million Private Placement(Yahoo Finance)
2022-10-03 01:45
TherapeuticsMD receives $7M investment after merger plans unravel(Bizjournals)
2022-10-02 18:50
TherapeuticsMD Announces $7 Million Private Placement(Yahoo Finance)
2022-09-11 18:50
TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers(Yahoo Finance)
2022-08-15 01:00
TherapeuticsMD, Inc. (TXMD) Q2 2022 Earnings Call Transcript(Fool)
2022-08-14 20:05
TherapeuticsMD (TXMD) Reports Q2 Loss, Tops Revenue Estimates(Yahoo Finance)

Page 1 of 4

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.